U.S. losing drug-research jobs to other countries
Eli Lilly and other big pharmaceutical companies are creating thousands of research jobs overseas as countries led by Singapore, Ireland and South Africa boost incentives.
Home » Search
Search Results
4,602 results for 'mental health'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
Company news
Louisville-based Neace Lukens has acquired Indianapolis-based Benefit Concepts Inc. to expand its benefits-consulting business in Indiana. Benefit Concepts' six employees will move into the Neace Lukens office at 6510 N. Shadeland Ave., reporting to Eric Chelovitz, Neace Lukens managing director of Indianapolis. Even before the acquisition, Neace Lukens had about 30 employees in Indiana. The firm was acquired in September by Florida-based AssuredPartners Inc. Numerous small-benefits consultants have sold their businesses in recent years to larger companies, first as employer efforts to change workers’ health habits hiked demands on brokers and now as the 2010 health reform law significantly curtails the health insurance commission system on which many health care brokers have survived for decades.
Purdue University's trustees approved plans Friday for a new campus medical clinic that administrators expect eventually will reduce the school's $151 million in annual health care costs for employees and their families. The clinic is scheduled to open this fall on the West Lafayette campus under a three-year contract paying about $14 million to a private provider, the Journal & Courier of Lafayette reported. The center will be available to all active employees and dependents covered by a Purdue medical plan. Primary and acute care will be offered, with patients not being charged for wellness coaching, chronic condition management and lab work for blood and other tests. Purdue's contract with clinic operator CHS of Reston, Va., is valued at $13.2 million to $14.7 million. The university's contribution to health care costs increased 6 percent, to $10,580 per employee, for 2012.
Bad news from a competitor has darkened the cloud over one of Eli Lilly and Co.’s most anticipated experimental drugs, evacetrapib, which has shown promise at boosting good cholesterol in heart patients. Swiss drugmaker Roche Holding AG said May 6 it has halted testing of its dalcetrapib, which the company had hoped would become a blockbuster, according to Bloomberg News. That move comes five years after New York-based Pfizer Inc. dumped a similar drug called torcetrapib due to safety issues. Lilly and New Jersey-based Merck & Co. Inc. still are developing their drugs in a class known as CETP inhibitors. Drugmakers have hoped that such drugs could replace statins as the next big medicine for heart patients. Statins, such as Pfizer’s Lipitor, were huge blockbusters, but most of them have now seen their patents expire. A Lilly spokeswoman told Bloomberg the Indianapolis-based company is committed to evacetrapib and plans to start a late-stage study in the second half of this year. A Phase 2 trial of the drug showed that it increases good cholesterol up to 129 percent and reduces bad cholesterol as much as 36 percent.
OBEIME: Poor, uninsured won’t monopolize resources
Myth prevents policymakers from attacking real problem of distributing funding.
Ex-Colt Schlichter’s latest sentence: 11 years
Ex-Ohio State and Indianapolis Colts quarterback Art Schlichter was sentenced Friday to nearly 11 years in federal prison for scamming participants in what authorities called a million-dollar sports ticket scheme.
Canal Walk popular, but full of opportunities missed
City leaders once envisioned the Canal Walk as a bustling pathway lined with restaurants and shops, but residential and office buildings have sprouted instead on most of the parcels along the meandering 1-1/2-mile stretch–making it more of a local amenity than a visitor attraction.
DINING: Making a meal at City Market
Last in a month-long series of reviews of eateries in and around City Market. This week: something from here and there.
IU Health to give $75 million to IU medical researchers
Indiana University Health announced Tuesday that it will give $75 million in additional funding over the next five years to ramp up research at the Indiana University School of Medicine and launch more clinical trials around the state.
People
Katherine Peck has been named executive associate dean for administration, operations and finance at the Indiana University School of Medicine. Peck was associate dean of financial services at the University of Florida College of Medicine. Before joining the University of Florida in 2000, Peck was the controller for several private companies in a variety of industries including biotechnology, manufacturing and environmental waste management. Peck holds a bachelor’s degree from Oberlin College and an MBA from Yale University School of Management.
Dr. Glenn Dobbs will provide obstetric services at Franciscan St. Francis Health’s Mooresville hospital. The arrival of Dobbs and the physician group he belongs to, Southside OB-GYN, helps Franciscan avoid a gap in obstetrics in Mooresville. The physician group that provides those services, Southwest Women’s Health, is scheduled to end its relationship with Franciscan-Mooresville in May. Dobbs, who specializes in high-risk obstetrics, did his medical training at Western University of Health Sciences in California.
Company news
Purdue University plans to start construction this summer on two academic buildings in a $79 million project for its newly designated Life and Health Sciences Park, according to the Journal & Courier of Lafayette. The $38 million Lyles-Porter Hall will house health programs, including Purdue's speech and hearing sciences department and the West Lafayette programs of the Indiana University School of Medicine. Purdue also is planning a $25 million Drug Discovery Building that will bring together pharmaceutical researchers from throughout the school. Plans are for the buildings and a new 850-space parking garage to be completed in 2014.
More than 70 workers will lose their jobs at Integra Specialty Hospital in Muncie when it closes in June. Hospital officials notified the Indiana Department of Workforce Development on Thursday that the 32-bed long-term-care facility will shut down on June 17. Renaissance Specialty Hospital of Central Indiana Operations Co. LLC, which operates Integra, did not provide a reason for the closing. The company said it expects that some of the 72 employees will be offered the opportunity to transfer to other long-term-care facilities.
Eli Lilly and Co. could receive up to $100 million from Washington, D.C.,-based Vanda Pharmaceuticals Inc., which licensed an alcohol-dependence drug from the Indianapolis drugmaker last week. The experimental drug, called LY686017, has been shown to reduce alcohol cravings and consumption in alcoholics. If it reaches the market, the drug would compete with Emend, a similar NK-1R antagonist made by New Jersey-based Merck & Co. Inc.
The government-contracting arm of WellPoint Inc. won a renewal of its contract, worth more than $111 million, to support the desktop program used by customer service representatives at the Centers for Medicare & Medicaid Services for the next five years. WellPoint’s National Government Services unit has held the contract since the program’s inception. The program helped Medicare’s call center field 26 million calls last year. NGS, which employs 2,000, also processed 170 million Medicare claims and administered benefits of $75.6 billion from the Medicare Trust Fund in 2011.
An animal rights group wants the federal government to fine a research institute owned by Indiana University Health for what it calls negligence toward animals, according to the Associated Press. The group Stop Animal Exploitation Now says IU Health's Methodist Research Institute had seven violations, including killing one dog and putting another dog in severe pain. According to a March report from the U.S. Department of Agriculture, a dog was fed before surgery, which violated proper protocol. The dog’s heart stopped, and it died. IU Health officials said in a statement that the use of animals in research has contributed significantly to advancements in health care.
New environmental board will need more expertise
Those who are concerned about public health and environmental protection should be disturbed by the elimination of the Air Pollution Control Board, the Water Pollution Control Board, and the Solid Waste Management Board and replacing them with a single Environmental Rules Board.
Carmel arts center makes room for more sponsors
The Center for the Performing Arts in Carmel expects the 2012-13 concert season, announced this week, to bring a healthy bump in sponsor revenue.
Is health care bubble about to burst?
Citigroup economist writes that U.S. health care sector "reminds us somewhat ominously of the bubble in housing finance" because public spending is fueling private profits.
CRAWFORD: Long list of accomplishments focused on education, health care
I am most proud of sponsoring legislation that stopped the executions of people who are mentally retarded.
New Lilly drug has small sales potential
Eli Lilly and Co.’s newest drug is a boon for Alzheimer’s research but is likely to bring the Indianapolis drugmaker less than $100 million in annual sales—at least initially, according to one of the few analysts to make a forecast.
Lugar, Mourdock prepare for lone debate in Senate race
Until now, Indiana's Senate Republican primary race between longtime U.S. Sen. Richard Lugar and Indiana Treasurer Richard Mourdock has been dominated by television ads, millions of campaign phone calls and foment among Indiana's strong base of conservative voters:
KENNEDY: Republicans losing the 51 percent
In a recent New York Times column, Gail Collins observed “the thing that makes our current politics particularly awful isn’t procedural. It’s that the Republican Party has become over-the-top extreme.” She left out “mean-spirited and patriarchal.”
Young Indy-area tech entrepreneurs enjoy deep support
MyJibe co-founder Mike Langellier is among a new generation of tech entrepreneurs in the Indianapolis area that benefits from a host of support their predecessors never enjoyed.
Supreme skepticism boosts WellPoint stock
Wall Street's favorable reaction came not only because harsh questioning by the U.S. Supreme Court’s conservative justices put in doubt the health reform law’s mandate that all Americans buy health insurance, but also because the justices raised the possibility that they would strike down requirements that insurers accept all customers, regardless of health.
MEREDITH: Respect, reverence has devolved to blame, distrust, sadness
The Indiana’s Department of Education appears to have an attitude that teaching is just a stopover on the way to something better.